Sign in

CIK 0001385818 · Non-accelerated filer<br>Smaller reporting company

AYTU BIOPHARMA, INC

Sign in to watch
Ticker
AYTU
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
DE
Entity type
operating
EIN
470883144
Phone
(720) 437-6580
Business address
7900 E. UNION AVENUE, SUITE 920, DENVER, CO, 80237
Former names
AYTU BIOSCIENCE, INC, Rosewind CORP
  1. 4 Grant or award Chief Executive Officer acquired 30,000 shares (grant or award)
  2. 4 Grant or award Chief Commercial Officer acquired 20,000 shares (grant or award)
  3. 4 Grant or award Chief Business Officer acquired 15,000 shares (grant or award)
  4. 4 Grant or award Chief Financial Officer acquired 25,000 shares (grant or award)
  5. 4 Grant or award Director acquired 10,000 shares (grant or award)
  6. 4 Grant or award Director acquired 10,000 shares (grant or award)
  7. 4 Grant or award Director acquired 10,000 shares (grant or award)
  8. 4 Grant or award Director acquired 10,000 shares (grant or award)
  9. 5 Insider Annual Insider Trading Report
  10. 4 Grant or award Chief Commercial Officer acquired 12,500 shares (grant or award)
  11. 4 Grant or award Chief Business Officer acquired 32,106 shares (grant or award)
  12. 4 Grant or award Chief Financial Officer acquired 33,743 shares (grant or award)
  13. 4 Grant or award Chief Executive Officer acquired 53,946 shares (grant or award)
  14. 4 Grant or award Director acquired 10,000 shares (grant or award)
  15. 4 Grant or award Director acquired 10,000 shares (grant or award)
  16. 4 Grant or award Director acquired 10,000 shares (grant or award)
  17. 4 Grant or award Director acquired 10,000 shares (grant or award)
  18. 4 Open-market buy Chief Business Officer bought 16,666 shares at $1.50 ($24,999)
  19. 4 Open-market buy Chief Executive Officer bought 66,666 shares at $1.50 ($99,999)
  20. 4 Derivatives Options or other derivatives

Page 1 of 10 · 187 filings